These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 17557769)

  • 1. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes.
    West SD; Nicoll DJ; Wallace TM; Matthews DR; Stradling JR
    Thorax; 2007 Nov; 62(11):969-74. PubMed ID: 17557769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: A randomised controlled trial.
    West SD; Kohler M; Nicoll DJ; Stradling JR
    Sleep Med; 2009 Oct; 10(9):1056-8. PubMed ID: 19427263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis.
    Feng Y; Zhang Z; Dong ZZ
    NPJ Prim Care Respir Med; 2015 Feb; 25():15005. PubMed ID: 25719929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 12-week continuous positive airway pressure therapy on glucose levels assessed by continuous glucose monitoring in people with type 2 diabetes and obstructive sleep apnoea; a randomized controlled trial.
    Banghøj AM; Krogager C; Kristensen PL; Hansen KW; Laugesen E; Fleischer J; Lebech Cichosz S; Poulsen PL; Glymer Kirkegaard M; Thorsteinsson B; Tarnow L
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00148. PubMed ID: 33855195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes. A Randomized Clinical Trial.
    Martínez-Cerón E; Barquiel B; Bezos AM; Casitas R; Galera R; García-Benito C; Hernanz A; Alonso-Fernández A; Garcia-Rio F
    Am J Respir Crit Care Med; 2016 Aug; 194(4):476-85. PubMed ID: 26910598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes.
    Harsch IA; Schahin SP; Brückner K; Radespiel-Tröger M; Fuchs FS; Hahn EG; Konturek PC; Lohmann T; Ficker JH
    Respiration; 2004; 71(3):252-9. PubMed ID: 15133345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Continuous Positive Airway Pressure on glycated hemoglobin in patients with type 2 diabetes and Obstructive Sleep Apnea.
    Gharsalli H; Oueslati I; Sahnoun I; Neffati O; Ghrairi N; Maalej S; Douik El Gharbi L
    Tunis Med; 2019 Dec; 97(12):1345-1352. PubMed ID: 32173803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of continuous positive airway pressure on glycaemic control and insulin resistance in patients with type 2 diabetes and obstructive sleep apnoea: A meta-analysis.
    Shang W; Zhang Y; Wang G; Han D
    Diabetes Obes Metab; 2021 Feb; 23(2):540-548. PubMed ID: 33146450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstructive sleep apnoea and diabetes: an update.
    Tahrani AA; Ali A; Stevens MJ
    Curr Opin Pulm Med; 2013 Nov; 19(6):631-8. PubMed ID: 24048079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure.
    Monneret D; Tamisier R; Ducros V; Faure P; Halimi S; Baguet JP; Lévy P; Pépin JL; Borel AL
    Respir Med; 2016 Mar; 112():119-25. PubMed ID: 26847407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis.
    Hecht L; Möhler R; Meyer G
    Ger Med Sci; 2011; 9():Doc20. PubMed ID: 21863134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure.
    Lam JCM; Lai AYK; Tam TCC; Yuen MMA; Lam KSL; Ip MSM
    Sleep Breath; 2017 May; 21(2):377-386. PubMed ID: 27817148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep.
    Dawson A; Abel SL; Loving RT; Dailey G; Shadan FF; Cronin JW; Kripke DF; Kline LE
    J Clin Sleep Med; 2008 Dec; 4(6):538-42. PubMed ID: 19110882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes.
    Mokhlesi B; Grimaldi D; Beccuti G; Van Cauter E
    Diabetes Obes Metab; 2017 Mar; 19(3):452-456. PubMed ID: 27860160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control?
    Steiropoulos P; Papanas N; Nena E; Tsara V; Fitili C; Tzouvelekis A; Christaki P; Maltezos E; Bouros D
    Sleep Med; 2009 Sep; 10(8):887-91. PubMed ID: 19231280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of continuous positive airway pressure (CPAP) preventing type 2 diabetes mellitus in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and insulin resistance: a systematic review and meta-analysis.
    Abud R; Salgueiro M; Drake L; Reyes T; Jorquera J; Labarca G
    Sleep Med; 2019 Oct; 62():14-21. PubMed ID: 31518943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstructive sleep apnoea and 12-month weight loss in adults with class 3 obesity attending a multidisciplinary weight management program.
    Kobuch S; Tsang F; Chimoriya R; Gossayn D; O'Brien S; Jamal J; Laks L; Tahrani A; Kormas N; Piya MK
    BMC Endocr Disord; 2021 Nov; 21(1):227. PubMed ID: 34774056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum urate levels are unchanged with continuous positive airway pressure therapy for obstructive sleep apnea: a randomized controlled trial.
    Prudon B; Roddy E; Stradling JR; West SD
    Sleep Med; 2013 Dec; 14(12):1419-21. PubMed ID: 24152796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apnea-hypnoea index (AHI).
    Sprung VS; Kemp GJ; Wilding JP; Adams V; Murphy K; Burgess M; Emegbo S; Thomas M; Needham AJ; Weimken A; Schwab RJ; Manuel A; Craig SE; Cuthbertson DJ
    BMJ Open; 2020 Jul; 10(7):e038856. PubMed ID: 32699168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study.
    Hoyos CM; Killick R; Yee BJ; Phillips CL; Grunstein RR; Liu PY
    Thorax; 2012 Dec; 67(12):1081-9. PubMed ID: 22561530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.